AbbVie, Shire agree on $55B combination

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home. Shire shareholders will receive stock valued at about 53.19 pounds ($91.07).